Resveratrol protects against oxidized LDL-induced breakage of the blood-brain barrier by lessening disruption of tight junctions and apoptotic insults to mouse cerebrovascular endothelial cells

Journal of Nutrition

Volumn 140, Issue 12, 2010, Pages 2187-2192

  Lin, Yi G ^a   Chang, Huai Chia ^a   Chen, Ta Liang ^a   Chang, Jin Han ^a   Chiu, Wen Ta ^a   Lin, Jia Wei ^a   Chen, Ruei Ming ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BETA ACTIN; CASPASE 3; CASPASE 9; CYTOCHROME C; F ACTIN; OCCLUDIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN ZO1; RESVERATROL;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL DEATH; CELL MEMBRANE PERMEABILITY; CEREBROVASCULAR ENDOTHELIAL CELL; CONTROLLED STUDY; CYTOSKELETON; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; HUMAN; MALE; MICROTUBULE; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOLAYER CULTURE; MOUSE; NONHUMAN; NORMAL HUMAN; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; TIGHT JUNCTION;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN; ENDOTHELIUM, VASCULAR; LIPOPROTEINS, LDL; MICE; STILBENES; TIGHT JUNCTIONS;

EID: 78649553696     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.123505     Document Type: Article

References (42)

1. Rubin LL. Endothelial cells: adhesion and tight junctions. Curr Opin Cell Biol. 1992;4:830-3.
2. Abbott NJ. Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat. 2002;200:629-38.
3. Engelhardt B. Development of the blood-brain barrier. Cell Tissue Res. 2003;314:119-29.
4. Huber JD, Egleton RD, Davis TP. Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci. 2001;24:719-25.
5. Lai CH, Kuo KH, Leo JM. Critical role of actin in modulating BBB permeability. Brain Res Brain Res Rev. 2005;50:7-13.
6. Betz AL. Alterations in cerebral endothelial cell function in ischemia. Adv Neurol. 1996;71:301-11, discussion 11-3.
7. de Vries HE, Blom-Roosemalen MC, de Boer AG, van Berkel TJ, Breimer DD, Kuiper J. Effect of endotoxin on permeability of bovine cerebral endothelial cell layers in vitro. J Pharmacol Exp Ther. 1996;277:1418-23.
8. Galea I, Felton LM, Waters S, van Rooijen N, Perry VH, Newman TA. Immune-to-brain signalling: the role of cerebral CD163-positive macrophages. Neurosci Lett. 2008;448:41-6.
9. van der Goes A, Wouters D, Van Der Pol SM, Huizinga R, Ronken E, Adamson P, Greenwood J, Dijkstra CD, de Vries HE. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J. 2001;15:1852-4.
10. Matsuura E, Hughes GR, Khamashta MA. Oxidation of LDL and its clinical implication. Autoimmun Rev. 2008;7:558-66.
11. Schrijvers DM, De Meyer GR, Kockx MM, Herman AG, Martinet W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler Thromb Vasc Biol. 2005;25:1256-61.
12. Zorn-Pauly K, Schaffer P, Pelzmann B, Bernhart E, Wei G, Lang P, Ledinski G, Greilberger J, Koidl B, et al. Oxidized LDL induces ventricular myocyte damage and abnormal electrical activity-role of lipid hydroperoxides. Cardiovasc Res. 2005;66:74-83.
13. Zettler ME, Prociuk MA, Austria JA, Zhong G, Pierce GN. Oxidized low-density lipoprotein retards the growth of proliferating cells by inhibiting nuclear translocation of cell cycle proteins. Arterioscler Thromb Vasc Biol. 2004;24:727-32.
14. Schroeter H, Spencer JP, Rice-Evans C, Williams RJ. Flavonoids protect neurons from oxidized low-density-lipoprotein-induced apoptosis involving c-Jun N-terminal kinase (JNK), c-Jun and caspase-3. Biochem J. 2001;358:547-57.
15. Chen TG, Chen TL, Chang HC, Tai YT, Cherng YG, Chang YT, Chen RM. Oxidized low-density lipoprotein induces apoptotic insults to mouse cerebral endothelial cells via a Bax-mitochondria-caspase protease pathway. Toxicol Appl Pharmacol. 2007;219:42-53.
16. Salvayre R, Auge N, Benoist H, Negre-Salvayre A. Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta. 2002;1585:213-21.
17. Pervaiz S. Resveratrol: from grapevines to mammalian biology. FASEB J. 2003;17:1975-85.
18. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Natl Rev Drug Discov. 2006;5:493-506.
19. Gusman J, Malonne H, Atassi G. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol. Carcinogenesis. 2001;22:1111-7.
20. Yoshida Y, Shioi T, Izumi T. Resveratrol ameliorates experimental autoimmune myocarditis. Circ J. 2007;71:397-404.
21. Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS. Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med. 2009;46:1589-97.
22. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev. 2005;57:173-85.
23. Xu J, Yeh CH, Chen S, He L, Sensi SL, Canzoniero LM, Choi DW, Hsu CY. Involvement of de novo ceramide biosynthesis in tumor necrosis factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem. 1998;273:16521-6.
24. Li D, Liu L, Chen H, Sawamura T, Ranganathan S, Mehta JL. LOX-1 mediates oxidized low-density lipoprotein-induced expression of matrix metalloproteinases in human coronary artery endothelial cells. Circulation. 2003;107:612-7.
25. Liu SX, Zhou M, Chen Y, Wen WY, Sun MJ. Lipoperoxidative injury to macrophages by oxidatively modified low density lipoprotein may play an important role in foam cell formation. Atherosclerosis. 1996;121:55-61.
26. Wu TT, Chen TL, Chen RM. Lipopolysaccharide triggers macrophage activation of inflammatory cytokine expression, chemotaxis, phagocytosis, and oxidative ability via a toll-like receptor 4-dependent pathway: validated by RNA interference. Toxicol Lett. 2009;191:195-202.
27. Chen RM, Wu CH, Chang HC, Wu GJ, Lin YL, Sheu JR, Chen TL. Propofol suppresses macrophage functions and modulates mitochondrial membrane potential and cellular adenosine triphosphate synthesis. Anesthesiology. 2003;98:1178-85.
28. Chang HC, Chen TL, Chen RM. Cytoskeleton interruption in human hepatoma HepG2 cells induced by ketamine occurs possibly through suppression of calcium mobilization and mitochondrial function. Drug Metab Dispos. 2009;37:24-31.
29. Lee ST, Wu TT, Yu PY, Chen RM. Apoptotic insults to human HepG2 cells induced by S-(+)-ketamine occurs through activation of a Bax-mitochondria- caspase protease pathway. Br J Anaesth. 2009;102:80-9.
30. Cherng YG, Chang HC, Lin YL, Kuo ML, Chiu WT, Chen RM. Apoptotic insults to human chondrocytes induced by sodium nitroprusside are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen-activated protein kinase kinase kinase-1/c-Jun N-terminal kinase, and Bax-mitochondria-mediated caspase activation. J Orthop Res. 2008;26:1018-26.
31. Chang HC, Lin KH, Tai YT, Chen JT, Chen RM. Lipoteichoic acid-induced TNF-alpha and IL-6 gene expressions and oxidative stress production in macrophages are suppressed by ketamine through downregulating tolllike receptor 2-mediated activation of ERK1/2 and NFkappaB. Shock. 2010;33:485-92.
32. Tai YT, Cherng YG, Chang CC, Hwang YP, Chen JT, Chen RM. Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/c-Jun-mediated Bcl-2 gene expression and protein translocation. J Orthop Res. 2007;25:625-35.
33. Chen TL, Chang CC, Lin YL, Ueng YF, Chen RM. Signal-transducing mechanisms of ketamine-caused inhibition of interleukin-1 beta gene expression in lipopolysaccharide-stimulated murine macrophage-like Raw 264.7 cells. Toxicol Appl Pharmacol. 2009;240:15-25.
34. Chang CC, Liao YS, Lin YL, Chen RM. Nitric oxide protects osteoblasts from oxidative stress-induced apoptotic insults via a mitochondria-dependent mechanism. J Orthop Res. 2006;24:1917-25.
35. Pervaiz S, Holme AL. Resveratrol: its biologic targets and functional activity. Antioxid Redox Signal. 2009;11:2851-97.
36. Yap AS, Manley SW. Microtubule integrity is essential for apical polarization and epithelial morphogenesis in the thyroid. Cell Motil Cytoskeleton. 2001;48:201-12.
37. Molitoris BA, Dahl R, Hosford M. Cellular ATP depletion induces disruption of the spectrin cytoskeletal network. Am J Physiol. 1996;271:F790-8.
38. Cavanaugh KJ Jr, Oswari J, Margulies SS. Role of stretch on tight junction structure in alveolar epithelial cells. Am J Respir Cell Mol Biol. 2001;25:584-91.
39. Ho WP, Chan WP, Hsieh MS, Chen RM. Runx2-mediated bcl-2 gene expression contributes to nitric oxide protection against hydrogen peroxide-induced osteoblast apoptosis. J Cell Biochem. 2009;108:1084-93.
40. Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci USA. 1997;94:3668-72.
41. Saikumar P, Dong Z, Patel Y, Hall K, Hopfer U, Weinberg JM, Venkatachalam MA. Role of hypoxia-induced Bax translocation and cytochrome c release in reoxygenation injury. Oncogene. 1998;17:3401-15.
42. Goyal L. Cell death inhibition: keeping caspases in check. Cell. 2001;104:805-8.